FDA Approves ZYRTEC ALLERGY — Kenvue Brands LLC

Kenvue Brands LLC received regulatory affirmation regarding ZYRTEC ALLERGY, a widely used oral tablet containing cetirizine hydrochloride that has cemented its stability in allergy management markets since the initial 2010 approval. With an approval history spanning over a decade, the branded prescription aligns with broader market trends favoring enduring, patented molecule franchises over generic erosion.